BioRestorative Therapies, Inc. (BRTX) stock
Close on Nov 11, 2026Market cap $39.75MP/E –Yield –
BioRestorative Therapies, Inc. saw revenue fall 8.5% to $357.87K over the twelve months to Mar 31, 2026. Free cash flow was -$10.91M. At the latest close the market valued the company at $39.75M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Mar 31, 2026
Valuation
- Market cap
- $39.75M
- P/E ratio
- –
- Price to sales
- 111.06
- Price to book
- 13.14
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $357.87K
- Net income
- -$11.06M
- EPS, diluted
- -$1.08
- Free cash flow
- -$10.91M
- Book value per share
- $0.17
- Diluted shares
- 18M
Trading
- Previous close
- $1.53
- Open
- $1.58
- Day's range
- $1.51 – $1.59
- Volume
- 12,843
- Average volume (20 days)
- 28,395
- Beta (5 years)
- 1.07
- 52-week range
- $1.28 – $29.00
- RSI (14 days)
- 41.3
- Volatility (1 year)
- 147.2%
- Relative volume
- 0.49×
- WACC
- 10.2%
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | BRTX | S&P 500 | Difference | BRTX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -18.3% | -2.4% | −15.9 pts | ||
| 3 months | -62.9% | -1.2% | −61.7 pts | ||
| Year to date | -93.4% | +12.3% | −105.7 pts | ||
| 1 year | -94.5% | +12.4% | −106.9 pts | ||
| 3 years | -95.9% | +78.8% | −174.7 pts | -65.4% | +21.4% |
| 5 years | -99.0% | +75.2% | −174.1 pts | -60.0% | +11.9% |
| 10 years | -100.0% | +311.1% | −411.1 pts | -70.1% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases BioRestorative Therapies filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- Update
- Results
- Update
About BioRestorative Therapies
Services-Misc Health & Allied Services, NEC
BioRestorative Therapies, Inc. is a clinical-stage biotechnology company that develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. Its lead candidate, BRTX-100, is an autologous mesenchymal stem cell therapy targeting painful lumbosacral disc disorders and chronic cervical discogenic pain. In addition, the company develops the ThermoStem Program, which uses brown adipose-derived stem cells to treat type 2 diabetes, obesity, hypertension, and related metabolic disorders. It also operates a commercial biocosmeceuticals business offering proprietary secretome-based biologic serums to address fine lines and cosmetic skin concerns.
Company profile, executives and historyBioRestorative Therapies stock: common questions
What is BioRestorative Therapies's stock price?
BRTX closed at $1.56 on Nov 11, 2026, up 1.96% on the day. Over the past 52 weeks it traded between $1.28 and $29.00.
What is BioRestorative Therapies's market cap?
BioRestorative Therapies was worth $39.75M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is BRTX's P/E ratio?
BioRestorative Therapies lost money over the twelve months to Mar 31, 2026 (diluted EPS -$1.08), so it has no meaningful P/E ratio.
How much revenue does BioRestorative Therapies make?
BioRestorative Therapies reported revenue of $357.87K for the twelve months to Mar 31, 2026, down 8.5% from a year earlier.
Does BioRestorative Therapies pay a dividend?
No. BioRestorative Therapies has not paid a cash dividend over the last twelve months.
How has BRTX stock performed over the past year?
Including dividends, BRTX returned -94.5% over the past year, against +12.4% for the S&P 500.
How many BRTX shares are sold short?
0M shares were sold short at the latest FINRA report, 0.16% of the float, or 1.0 days of average trading volume.
Who are BioRestorative Therapies's competitors?
Companies most similar to BioRestorative Therapies by business, industry and size include MGRX, BICX, YDES, ARTV, ERNA.
See a number that looks wrong?